Packaging and storage— Preserve in tight, single-dose or multiple-dose containers.

USP Reference standards 11— USP Colestipol Hydrochloride RS.

Minimum fill 755: meets the requirements for powders.

Water-soluble substances— Transfer 5.0 g of Colestipol Hydrochloride for Oral Suspension, accurately weighed, to a glass-stoppered, 125-mL conical flask, add 80.0 mL of water, insert the stopper in the flask, and mount the flask in a water-bath shaker maintained at 37 ± 1. Operate the shaker for 72 hours, remove the flask from the shaker, and filter the contents through a fine-porosity, fritted-glass funnel, collecting the filtrate in a tared 100-mL fused quartz crucible. Rinse any residual test material in the flask with two 5-mL portions of water, pass the washings through the filter, and combine the filtrates from the washings with the filtrate from the test mixture. Evaporate the filtrate to dryness, filtered air or nitrogen being used, if necessary, to aid in the evaporation. Dry the residue in a vacuum oven maintained at 75 for 1 hour, allow to cool in a desiccator, and weigh. Calculate the initial percentage of water-soluble substances in the portion of Colestipol Hydrochloride for Oral Suspension taken. Again heat the residue in a muffle furnace maintained at 800 ± 25 for 4 hours, allow to cool in a desiccator, and weigh. Calculate the percentage of inert ingredients present. Calculate the actual percentage of water-soluble substances in the portion of Colestipol Hydrochloride for Oral Suspension taken by subtracting the percentage of inert ingredients from the initial percentage of water-soluble substances found. Not more than 0.5% of water-soluble substances is found.

Residual solvents 467: meets the requirements.

Other requirements— Meets the requirements of the tests for Cholate binding capacity, Identification, and pH under Colestipol Hydrochloride.

Expert Committee : (MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine

USP29–NF24 Page 588

Phone Number : 1-301-816-8251